Irene Jarchum
About Irene Jarchum
Irene Jarchum is the Associate Director of the International Immuno-Oncology Network at Bristol Myers Squibb, with a rich background in immunology research and scientific communication.
Current Role at Bristol Myers Squibb
Irene Jarchum currently holds the position of Associate Director at the International Immuno-Oncology Network (II-ON) within Bristol Myers Squibb. In her role, she collaborates with global partners to advance immuno-oncology research, focusing on innovative therapies to treat cancer. Her work involves coordinating research efforts, overseeing clinical trial collaborations, and contributing to the overall strategic direction of the network.
Previous Experience at Immunai
From 2020 to 2021, Irene Jarchum worked as a Scientific Liaison at Immunai, based in New York. During her 8-month tenure, she led a collaborative project that aimed to map the human immune system using single-cell genomics. This role involved significant cross-functional coordination, leveraging her expertise in immunology to facilitate groundbreaking research initiatives.
Tenure at Springer Nature
For seven years, from 2013 to 2020, Irene Jarchum served as Senior Editor at Nature Biotechnology, a part of Springer Nature. In this capacity, she was responsible for overseeing the publication of high-impact research articles in the field of biotechnology. Her editorial work ensured the dissemination of cutting-edge scientific findings to the global research community.
Research at Tisch MS Research Center of New York
Between 2012 and 2013, Irene Jarchum worked as a Research Associate at the Tisch MS Research Center of New York. She mentored junior researchers and postdoctoral fellows, contributing to the center's mission to develop innovative therapies for multiple sclerosis. Her role emphasized both research and mentorship, fostering a collaborative environment for scientific discovery.
Education and Research at Memorial Sloan-Kettering Cancer Center
Irene Jarchum was a Research Scholar at Memorial Sloan-Kettering Cancer Center from 2009 to 2012. During this period, she published multiple research articles in high-impact journals and received a prestigious fellowship for her postdoctoral research. Her work at Memorial Sloan-Kettering significantly advanced the understanding of cancer immunology, contributing to the development of novel immunotherapy approaches currently in clinical trials.
Academic Background
Irene Jarchum earned her Doctor of Philosophy (PhD) in Biomedical Sciences (Immunology) from the Albert Einstein College of Medicine of Yeshiva University, where she studied from 2003 to 2009. Her doctoral research laid the foundation for her subsequent contributions to the field of immuno-oncology, equipping her with extensive expertise in immunology and biomedical sciences.